Healthcare Professionals should carefully monitor patients during treatment with finasteride for psychiatric symptoms (including anxiety, depression and suicidal ideation). If a patient treated with 1 mg finasteride develops psychiatric symptoms, treatment should be stopped.
—Direct Healthcare Professional Communication letter, October 4, 2018